1,513
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Baseline and longitudinal cardiovascular health using Life’s Essential 8 metrics with the risk of incident hypertension

, , , , , , , & show all
Article: 2271190 | Received 03 Jul 2023, Accepted 10 Oct 2023, Published online: 20 Nov 2023

References

  • Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 2016;387(10022):957–9. doi:10.1016/S0140-6736(15)01225-8.
  • Iadecola C, Gottesman RF. Neurovascular and cognitive dysfunction in hypertension. Circ Res. 2019;124(7):1025–44. doi:10.1161/CIRCRESAHA.118.313260.
  • Hamrahian SM, Falkner B. Hypertension in chronic kidney disease. Adv Exp Med Biol. 2017;956:307–25.
  • Frisoli TM, Schmieder RE, Grodzicki T, Messerli FH. Beyond salt: lifestyle modifications and blood pressure. Eur Heart J. 2011;32(24):3081–87. doi:10.1093/eurheartj/ehr379.
  • Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47(2):296–308. doi:10.1161/01.HYP.0000202568.01167.B6.
  • Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH, Messerli FH, Oparil S, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354(16):1685–97. doi:10.1056/NEJMoa060838.
  • Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613. doi:10.1161/CIRCULATIONAHA.109.192703.
  • Grandner MA, Fernandez FX. The translational neuroscience of sleep: a contextual framework. Sci. 2021;374(6567):568–73. doi:10.1126/science.abj8188.
  • Lloyd-Jones DM, Allen NB, Anderson CAM, Black, T, Brewer, LC, Foraker, RE, Grandner, MA, Lavretsky, H, Perak, AM, Sharma, G, et al. Status of cardiovascular health in US adults and children using the American Heart Association’s new “Life’s Essential 8” metrics: prevalence estimates from the National Health and Nutrition Examination Survey (NHANES), 2013-2018, Circulation, 2022;146(11):822–835.
  • Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, Grandner MA, Lavretsky H, Perak AM, Sharma G, et al. Life’s Essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18–e43.
  • Suzuki Y, Kaneko H, Yano Y, Okada A, Itoh H, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, et al. Association of cardiovascular health metrics with risk of transition to hypertension in non-hypertensive young adults. Am J Hypertens. 2022;35(10):858–66. doi:10.1093/ajh/hpac057.
  • Langford AT, Butler M, Booth JN, Jin P, Bress AP, Tanner RM, Kalinowski J, Blanc J, Seixas A, Shimbo D, et al. Stress and depression are associated with Life’s simple 7 among African Americans with hypertension: findings from the Jackson Heart study. Am J Hypertens. 2021;34(12):1311–21. doi:10.1093/ajh/hpab116.
  • Zhao H, Wu Y, Sun J, Zu C, Ruan C, Cui K, He H, Wu S, Peng X. Influence of gestational hypertension on cardiovascular health behaviors and factors. Comput Intell Neurosci. 2022;2022:1–7.
  • Jin C, Chen S, Vaidya A, Wu Y, Wu Z, Hu FB, Kris-Etherton P, Wu S, Gao X. Longitudinal change in fasting blood glucose and myocardial infarction risk in a population without diabetes. Diab Care. 2017;40(11):1565–72. doi:10.2337/dc17-0610.
  • Li Y, Huang Z, Jin C, Xing A, Liu Y, Huangfu C, Lichtenstein AH, Tucker KL, Wu S, Gao X, et al. Longitudinal change of perceived salt intake and stroke risk in a Chinese population. Stroke. 2018;49(6):1332–39. doi:10.1161/STROKEAHA.117.020277.
  • Zhang R, Xie J, Yang R, Li R, Chong M, Zhang X, Chen S, Wu S, Yang Y. Association between ideal cardiovascular health score trajectories and arterial stiffness: the Kailuan study. Hypertens Res. 2020;43(2):140–47. doi:10.1038/s41440-019-0341-4.
  • Zhang Q, Zhou Y, Gao X, Wang C, Zhang S, Wang A, Li N, Bian L, Wu J, Jia Q, et al. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke. 2013;44(9):2451–56. doi:10.1161/STROKEAHA.113.678839.
  • Liu X, Cui L, Wang A, Wang X, Song Q, Li S, Shi J, Zhao X, Chen S, Du X, et al. Cumulative exposure to ideal cardiovascular health and incident diabetes in a Chinese population: the Kailuan study. J Am Heart Assoc. 2016;5(9). doi:10.1161/JAHA.116.004132.
  • Wu S, Huang Z, Yang X, Zhou Y, Wang A, Chen L, Zhao H, Ruan C, Wu Y, Xin A, et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes. 2012;5(4):487–93. doi:10.1161/CIRCOUTCOMES.111.963694.
  • Li Z, Meng L, Huang Z, Cui L, Li W, Gao J, Wang Z, Zhang R, Zhou J, Zhang G, et al. Ideal cardiovascular health metrics and incident hyperuricemia. Arthritis Care Res (Hoboken). 2016;68(5):660–66. doi:10.1002/acr.22830.
  • Wang X, Liu F, Li J, Yang X, Chen J, Cao J, Wu X, Lu X, Huang J, Li Y, et al. Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: the China-PAR project. Eur J Prev Cardiol. 2020;27(18):1956–63. doi:10.1177/2047487319894685.
  • Han C, Liu F, Yang X, Chen J, Li J, Cao J, Li Y, Shen C, Yu L, Liu Z, et al. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project. Sci China Life Sci. 2018;61(5):504–14. doi:10.1007/s11427-018-9281-6.
  • Xing A, Tian X, Wang Y, Chen S, Xu Q, Xia X, Zhang Y, Zhang X, Wang A, Wu S, et al. ‘Life’s essential 8’ cardiovascular health with premature cardiovascular disease and all-cause mortality in young adults: the Kailuan prospective cohort study. Eur J Prev Cardiol. 2023;30(7):593–600. doi:10.1093/eurjpc/zwad033.
  • Wu S, Wu Z, Yu D, Chen S, Wang A, Wang A, Gao X. Life’s essential 8 and risk of Stroke: a prospective community-based study. Stroke. 2023;54(9):2369–79. doi:10.1161/STROKEAHA.123.042525.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report, Jama. 2003;289(19):2560–72. doi:10.1001/jama.289.19.2560.
  • Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;20182018:e484–e594.
  • Plante TB, Koh I, Judd SE, Howard G, Howard VJ, Zakai NA, Booth JN, Safford MM, Muntner P, Cushman M, et al. Life’s simple 7 and incident hypertension: the REGARDS study. J Am Heart Assoc. 2020;9(19):e016482. doi:10.1161/JAHA.120.016482.
  • Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M, Bixler EO. Insomnia with objective short sleep duration and incident hypertension: the Penn state cohort. Hypertension. 2012;60(4):929–35. doi:10.1161/HYPERTENSIONAHA.112.193268.
  • Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32(4):491–97. doi:10.1093/sleep/32.4.491.
  • Bathgate CJ, Fernandez-Mendoza J. Insomnia, short sleep duration, and high blood pressure: recent evidence and future directions for the prevention and management of hypertension. Curr Hypertens Rep. 2018;20(6):52. doi:10.1007/s11906-018-0850-6.
  • Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–67. doi:10.1038/nature05485.
  • Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J. 2006;70(11):1437–42. doi:10.1253/circj.70.1437.
  • Canale MP, Manca di Villahermosa S, Martino G, Rovella V, Noce A, De Lorenzo A, Di Daniele N. Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. Int J Endocrinol. 2013;2013:1–12. doi:10.1155/2013/865965.
  • Carnethon MR, Evans NS, Church TS, Lewis CE, Schreiner PJ, Jacobs DR, Sternfeld B, Sidney S. Joint associations of physical activity and aerobic fitness on the development of incident hypertension: coronary artery risk development in young adults. Hypertension. 2010;56(1):49–55. doi:10.1161/HYPERTENSIONAHA.109.147603.
  • Tromp J, Paniagua SMA, Lau ES, Allen NB, Blaha MJ, Gansevoort RT, Hillege HL, Lee DE, Levy D, Vasan RS, et al. Age dependent associations of risk factors with heart failure: pooled population based cohort study. Bmj. 2021;372:n461.
  • Dugani SB, Moorthy MV, Li C, Demler OV, Alsheikh-Ali AA, Ridker PM, Glynn RJ, Mora S. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary Heart disease in women. JAMA Cardiol. 2021;6(4):437–47. doi:10.1001/jamacardio.2020.7073.
  • Karmali KN, Goff DC Jr., Ning H, Lloyd-Jones DM. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2014;64(10):959–68. doi:10.1016/j.jacc.2014.06.1186.
  • Tsai MC, Lee CC, Liu SC, Tseng P-J, Chien K-L. Combined healthy lifestyle factors are more beneficial in reducing cardiovascular disease in younger adults: a meta-analysis of prospective cohort studies. Sci Rep. 2020;10(1):18165. doi:10.1038/s41598-020-75314-z.
  • Goossens GH, Jocken JWE, Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47–66. doi:10.1038/s41574-020-00431-8.
  • Woodward M. Cardiovascular disease and the female disadvantage. Int J Environ Res Public Health. 2019;16(7):1165. doi:10.3390/ijerph16071165.
  • Huffman MD, Capewell S, Ning H, Shay CM, Ford ES, Lloyd-Jones DM. Cardiovascular health behavior and health factor changes (1988–2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys, Circulation. 2012;125(21):2595–602. doi:10.1161/CIRCULATIONAHA.111.070722.